Literature DB >> 8811167

Lyme neuroborreliosis in children.

H J Christen1.   

Abstract

Children are more likely than adults to be bitten by ticks and thus more likely to be infected by Borrelia burgdorferi. In a serosurvey the infection rate measured by immunoglobulin G (IgG) antibodies was 2.6%. In a prospective hospital-based multicentre study 169 children with Lyme neuroborreliosis were examined; the infection was diagnosed by detection of specific immunoglobulin M (IgM) antibodies in the cerebrospinal fluid (CSF) using an IgM capture ELISA. The yearly incidence of Lyme neuroborreliosis was 5.8 cases per 100,000 children aged 1-13. Facial palsy and lymphocytic meningitis account for nearly 90% of all cases with neuroborreliosis indicating striking differences in the clinical spectrum between children and adults. Lyme borreliosis proves to be the most frequently verifiable cause of acute peripheral facial palsy in children, causing every second case of this disorder in the summer and autumn. In cases of facial palsy, nearly all patients with a positive history of tick bite or erythema migrans in the head and neck region show ipsilateral subsequent facial nerve palsy, suggesting a direct invasion via the affected nerve by Borrelia burgdorferi. Lyme borreliosis is the third most frequent cause of lymphocytic meningitis in childhood. Inflammatory changes of the cerebrospinal fluid along with the presence of specific antibodies are mandatory for the diagnosis of Lyme neuroborreliosis. High-dose intravenous penicillin G as well as third-generation cephalosporins prove to be effective in paediatric Lyme neuroborreliosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811167     DOI: 10.3109/07853899609033125

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  14 in total

1.  Lyme Neuroborreliosis.

Authors:  Sebastian Rauer; Stefan Kastenbauer; Volker Fingerle; Klaus-Peter Hunfeld; Hans-Iko Huppertz; Rick Dersch
Journal:  Dtsch Arztebl Int       Date:  2018-11-09       Impact factor: 5.594

2.  Facial paralysis and lymphocytic facial neuritis in a rhesus macaque (Macaca mulatta) positive for simian retrovirus type D2.

Authors:  Anna L Hampton; Lesley A Colby; Ingrid L Bergin
Journal:  Comp Med       Date:  2011-12       Impact factor: 0.982

3.  Pediatric tick-borne infections of the central nervous system in an endemic region of Sweden: a prospective evaluation of clinical manifestations.

Authors:  Mikael Sundin; Magnus E A Hansson; Mona-Lisa Engman; Claes Orvell; Lars Lindquist; Katarina Wide; Karl-Johan Lidefelt
Journal:  Eur J Pediatr       Date:  2011-08-13       Impact factor: 3.183

4.  Tick bite and Lyme borreliosis risk at a recreational site in England.

Authors:  J N Robertson; J S Gray; P Stewart
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 5.  What we have learned about Lyme borreliosis from studies in children.

Authors:  Sunil K Sood
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 6.  [Neuroborreliosis].

Authors:  R Kaiser; V Fingerle
Journal:  Nervenarzt       Date:  2009-10       Impact factor: 1.214

7.  [Pain and neuroborreliosis: significance, diagnosis and treatment].

Authors:  T A Rupprecht; T Birnbaum; H-W Pfister
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

8.  Evaluation of the underlying causes of papilledema in children.

Authors:  Robert A Hyde; Mehmet C Mocan; Urmi Sheth; Lawrence M Kaufman
Journal:  Can J Ophthalmol       Date:  2019-04-04       Impact factor: 1.882

9.  Diastolic heart murmur, nocturnal back pain, and lumbar rigidity in a 7-year girl: an unusual manifestation of lyme disease in childhood.

Authors:  Genn Kameda; Silvia Vieker; Johannes Hartmann; Tim Niehues; Alfred Längler
Journal:  Case Rep Pediatr       Date:  2012-09-29

10.  The NeBoP score - a clinical prediction test for evaluation of children with Lyme Neuroborreliosis in Europe.

Authors:  Barbro H Skogman; Johanna Sjöwall; Per-Eric Lindgren
Journal:  BMC Pediatr       Date:  2015-12-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.